A total of fourteen previous meta-analyses [19–32] between 2004 and 2016 have been published to analyze the individual GSTM1 present/null, GSTT1 present/null, and/or GSTP1 IIe105Val polymorphisms on breast cancer (BC) risk. This evidence concerns the gene GSTM1 and breast cancer.